75 results on '"Trachtenberg, Barry H."'
Search Results
2. Contributors
3. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
4. Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
5. Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation
6. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study
7. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study
8. Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
9. Targeted treatments of AL and ATTR amyloidosis
10. Presence of the V122I Variant of Hereditary Transthyretin-Mediated Amyloidosis Among Self-Reported White Individuals in a Sponsored Genetic Testing Program
11. Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support
12. Defining Vasoplegia Following Durable, Continuous Flow Left Ventricular Assist Device Implantation
13. A principal components analysis of factors associated with successful implementation of an LVAD decision support tool
14. Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
15. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
16. Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery
17. Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
18. A Principal Components Analysis of Factors Associated with Successful Implementation of an LVAD Decision Support Tool
19. A Principal Components Analysis of Factors Associated with Successful Implementation of an LVAD Decision Support Tool
20. Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation
21. Baseline Global Longitudinal Strain Predictive of Anthracycline-Induced Cardiotoxicity
22. Should We Be for ASCT?
23. A positive Tc-99m PYP scan in a patient with cardiac sarcoidosis
24. Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
25. The Burgeoning Field of Cardio-Oncology
26. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis
27. Barry H. Trachtenberg Leads Issue on Cardio-Oncology
28. Cardiotoxicity of Immune Checkpoint Inhibitors in Patients with Lung Cancer
29. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure
30. Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation
31. A Young Woman with an Acute Illness and Chest Pain
32. Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk Patient
33. Inflammatory Cardiomyopathic Syndromes
34. Anemia after Continuous-flow Left Ventricular Assist Device Implantation: Characteristics and Implications
35. Roads, Maps, and Destinations: the Journey of Left Ventricular Assist Device Implantation in Ambulatory Patients with Advanced Heart Failure
36. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial
37. Deflation Timing Influences Intra-Aortic Balloon Pump–Mediated Carotid Blood Flow Reversal
38. Incidence and Outcomes of Chemotherapy-Induced Cardiomyopathy Patients among Referrals for Advanced Heart Failure
39. Iron Deficiency Is the Most Common Cause of Anemia in CF-LVAD Patients
40. Reduction in Healthcare Utilization in Patients with Remote Hemodynamic Pulmonary Artery Pressure Monitoring Device: A Real-World, Post Clinical Trial Single Center Experience
41. Evidence of Endothelial to Mesenchymal Transition (EndMT) in the Clinically Non-Failing Left Ventricles (CNFL)
42. Aging in Heart Transplant: Gene Expression and Molecular Mechanisms
43. Local Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression
44. Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications
45. Vascular Reactivity Analysis in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVADs) - the Role of Endothelial Function in Continuous Flow Physiology
46. Presence of Endothelial to Mesenchymal Transition in End Stage Human Myocardial Samples-documentation in Human Heart Failure for the First Time
47. Temporal Assessment of Endothelial to Mesenchymal Transition as a Contributor to Fibrosis in a Mouse Model of Heart Failure
48. Elevated Transpulmonary Gradient is a Predictor of Survival in Patients with WHO Group II Pulmonary Hypertension Treated with Continuous-flow Left Ventricular Assist Devices (CF-LVAD)
49. Efficacy and Safety of Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection in Orthotopic Heart Transplant
50. Heart Transplant Donor Characteristics Associated with Worse Outcomes Differ Between Patients who are Bridged Continuous Flow LVAD and Non-bridged Patients: an Analysis of the UNOS Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.